According to Sanxin Medical's announcement, Jiangxi Colevipid Biotechnology Co., Ltd., a second-tier holding subsidiary of the company, recently obtained the “Medical Device Registration Certificate” for a blood leak monitor issued by the Jiangxi Drug Administration. The registration certificate is valid from October 16, 2026 to October 15, 2031. It is a Class II medical device and is used to monitor and alarm blood leakage at the patient's puncture site. This product is a second-class innovative medical device in Jiangxi Province. This certification further enriches the company's product matrix in the field of peripheral vascular intervention. It will have a positive impact on future operations, and it is not yet possible to predict its specific impact on future performance.

According to Sanxin Medical's announcement, Jiangxi Colevipid Biotechnology Co., Ltd., a second-tier holding subsidiary of the company, recently obtained the “Medical Device Registration Certificate” for a blood leak monitor issued by the Jiangxi Drug Administration. The registration certificate is valid from October 16, 2026 to October 15, 2031. It is a Class II medical device and is used to monitor and alarm blood leakage at the patient's puncture site. This product is a second-class innovative medical device in Jiangxi Province. This certification further enriches the company's product matrix in the field of peripheral vascular intervention. It will have a positive impact on future operations, and it is not yet possible to predict its specific impact on future performance.